# DOMA Biopharmaceutical (Suzhou) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/doma-biopharmaceutical-suzhou-co

- Industry: Business Support Services
- Headquarters: Suzhou, China
- Website: www.domabio.com
- Total disclosed funding: $142M
- Latest round: Series A (Jun 1, 2022)
- Investors on record: 6

## About

Based in Suzhou, China, and founded in 2021, DOMA Biopharmaceutical (Suzhou) Co., Ltd operates as a biotech company that focuses on the development of health industry. The company's Chairman of board, Dr. Yuelei Shen graduated from Wuhan University. He was the founder, CEO, and Chairman of Board of Biocytogen Biotechnology. 

The company's incubation platform provides enterprises with office and experimental origin leasing, early risk capital, clinical research registration and management, shared space, enterprise registration, human resources, patent affairs, legal affairs and other services.

## Funding rounds

- Series A, Jun 1, 2022, $142M — PICC Capital Equity Investment, CMB International Asset Management, Biocytogen Biotechnology, China Life Capital, Beiguotou Equity Investment Fund Management, Taiping Innovation Investment Management

## Investors

- PICC Capital Equity Investment (https://capitalatlas.ai/funds/picc-capital-equity-investment) — Series A
- CMB International Asset Management (https://capitalatlas.ai/funds/cmb-international-asset-management) — Series A
- Biocytogen Biotechnology — Series A
- China Life Capital — Series A
- Beiguotou Equity Investment Fund Management (https://capitalatlas.ai/funds/beiguotou-equity-investment-fund-management) — Series A
- Taiping Innovation Investment Management — Series A